Autopsy report · NCT03706053

Midodrine Use in Septic Shock

“No funding for the study; not enough staff”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 3 years 3 months before it stopped.
• 10 participants enrolled.
• Results were posted on the registry 3 years 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

University of Virginia

Sponsor type

University, hospital or other

Conditions

Septic Shock

Interventions

Midodrine Hydrochloride; placebo

Participants

10

Sites

1

Countries

United States

Trials that died the same way

• Regulation of the Release of Inflammatory Mediators From Blood Leukocytes
  “No funding for the study” (90% match in meaning)
• Study of EQU-001 for Uncontrolled Focal Onset Seizures
  “insufficient funding to complete the study” (88% match in meaning)
• Efficacy of Kerecis Omega 3 in Comparison to Clinical Standard Procedures
  “Lack of funding to support the study” (88% match in meaning)
• Vasomotor Symptoms and Cardiovascular Control
  “No funding obtained to conduct study” (87% match in meaning)
• L-tetrahydropalmatine (l-THP) Treatment for Cocaine Use Disorder
  “Study funding has not been established” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.